Hong Kong · Delayed Price · Currency is HKD AK Medical Holdings Statistics
Total Valuation
HKG:1789 has a market cap or net worth of HKD 6.53 billion. The enterprise value is 5.24 billion.
| Market Cap | 6.53B |
| Enterprise Value | 5.24B |
Important Dates
The next estimated earnings date is Wednesday, June 3, 2026.
| Earnings Date | Jun 3, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
HKG:1789 has 1.12 billion shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 1.12B |
| Shares Outstanding | 1.12B |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 51.63% |
| Owned by Institutions (%) | 18.20% |
| Float | 539.98M |
Valuation Ratios
The trailing PE ratio is 17.35 and the forward PE ratio is 14.19.
| PE Ratio | 17.35 |
| Forward PE | 14.19 |
| PS Ratio | 3.96 |
| PB Ratio | 2.01 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | 20.22 |
| P/OCF Ratio | 14.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 16.22.
| EV / Earnings | 13.89 |
| EV / Sales | 3.18 |
| EV / EBITDA | 9.82 |
| EV / EBIT | 12.60 |
| EV / FCF | 16.22 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.10 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.30 |
| Interest Coverage | 127.13 |
Financial Efficiency
Return on equity (ROE) is 12.22% and return on invested capital (ROIC) is 18.30%.
| Return on Equity (ROE) | 12.22% |
| Return on Assets (ROA) | 6.68% |
| Return on Invested Capital (ROIC) | 18.30% |
| Return on Capital Employed (ROCE) | 12.44% |
| Weighted Average Cost of Capital (WACC) | 2.35% |
| Revenue Per Employee | 1.68M |
| Profits Per Employee | 384,656 |
| Employee Count | 983 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.23 |
Taxes
In the past 12 months, HKG:1789 has paid 62.19 million in taxes.
| Income Tax | 62.19M |
| Effective Tax Rate | 14.15% |
Stock Price Statistics
The stock price has increased by +2.81% in the last 52 weeks. The beta is -0.35, so HKG:1789's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | +2.81% |
| 50-Day Moving Average | 6.35 |
| 200-Day Moving Average | 6.02 |
| Relative Strength Index (RSI) | 33.47 |
| Average Volume (20 Days) | 4,213,226 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1789 had revenue of HKD 1.65 billion and earned 377.35 million in profits. Earnings per share was 0.34.
| Revenue | 1.65B |
| Gross Profit | 998.63M |
| Operating Income | 416.06M |
| Pretax Income | 439.54M |
| Net Income | 377.35M |
| EBITDA | 517.83M |
| EBIT | 416.06M |
| Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 1.39 billion in cash and 96.18 million in debt, with a net cash position of 1.29 billion or 1.16 per share.
| Cash & Cash Equivalents | 1.39B |
| Total Debt | 96.18M |
| Net Cash | 1.29B |
| Net Cash Per Share | 1.16 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 2.88 |
| Working Capital | 2.27B |
Cash Flow
In the last 12 months, operating cash flow was 440.65 million and capital expenditures -117.60 million, giving a free cash flow of 323.06 million.
| Operating Cash Flow | 440.65M |
| Capital Expenditures | -117.60M |
| Depreciation & Amortization | 105.92M |
| Net Borrowing | -12.91M |
| Free Cash Flow | 323.06M |
| FCF Per Share | 0.29 |
Margins
Gross margin is 60.54%, with operating and profit margins of 25.22% and 22.87%.
| Gross Margin | 60.54% |
| Operating Margin | 25.22% |
| Pretax Margin | 26.64% |
| Profit Margin | 22.87% |
| EBITDA Margin | 31.39% |
| EBIT Margin | 25.22% |
| FCF Margin | 19.58% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 60.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.71% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 1.92% |
| Earnings Yield | 5.78% |
| FCF Yield | 4.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1789 is 8.12, which is 38.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 8.12 |
| Price Target Difference | 38.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1789 has an Altman Z-Score of 6.81 and a Piotroski F-Score of 8.
| Altman Z-Score | 6.81 |
| Piotroski F-Score | 8 |